Interim results for the period ended 31 July 2024

Source: RNS
RNS Number : 3739E
Milton Capital PLC
17 September 2024
 

17 September 2024

Milton Capital Plc

Unaudited interim results for the period ended 31 July 2024

Milton Capital Plc ("Milton" or the "Company") is pleased to announce its interim results for the six months ending 31 July 2024.

Highlights:

·    The Company recorded a loss before tax of £201,058 (2023: loss of £33,841) and had cash balances of £531,615 (2023: £910,589) at the end of the period.

·    Search for a suitable acquisition target continues.

Enquiries 

Peterhouse Capital Limited

 

 

 

Financial Adviser

Tel: +44 (0) 20 7469 0930



Corporate Broker

Tel: +44 (0) 20 7469 0930

 

CHAIRMAN'S STATEMENT

In the past half-year we have sought to identify suitable assets to introduce to the Company.   We have pursued an active business development programme and screened a large number of potential opportunities. Our aim has been to identify  a suitable RTO (Reverse Takeover) candidate; one meeting our high expectations on technical merit and one also capable of being financed. As is the nature of pursuing a programme many opportunities fall by the wayside, some only late in the day, not standing up to the rigorous due diligence or unrealistic commercial expectations of vendors in relation to the asset. Notwithstanding market and geo-political  challenges, we are confident in the Company's long-term prospects, primarily due to a number of opportunities that have stood up to extensive geological and geophysical review and going through later steps of maturation. During this period, recognising that running a public company has intrinsic costs and professionally screening opportunities is expensive,  we remain committed to cost-efficiency, as we persist in our quest for a suitable acquisition target. Further updates regarding our acquisition search will be provided in due time. It remains the case, and in line with our listing prospectus, in the event we have not progressed with a transaction by October 2024, we will revert to our Shareholders with a full update.



Richard Mays

Executive Chairman

 

 

Responsibility Statement

The following statement is given by each of the Directors.

We confirm that to the best of our knowledge:

·    the interim report has been prepared in accordance with International Accounting Standards 34, Interim Financial Reporting, as contained in UL adopted IFRS;

·    gives a true and fair view of the assets, liabilities, financial position and loss of the Company; and

·    the interim report includes a fair review of the information required by DTR 4.2.7R of the Disclosure and Transparency Rules, being an indication of important events that have occurred during the first six months of the financial year and their impact on the set of interim financial statements; and a description of the principal risks and uncertainties for the remaining six months of the year.

·    the interim report includes a fair review of the information required by DTR 4.2.8R of the Disclosure and Transparency Rules, being the information required on related party transactions.

·    The interim report was approved by the Board of Directors and the above responsibility statement was signed on its behalf by:

 

 

Edward Dawson

Director

16 September 2024

 

Condensed income statement

For the six months ended 31 July 2024

 



  Six months ended

 

  Six months ended

 

Year ended

 


31 July

 

31 July

 

31 January

 


2024


2023


2024



(unaudited)

 

(unaudited)

 

(audited)

 


£


£


£








CONTINUING OPERATIONS

 






Administrative expenses


(199,655)


(33,841)


(193,271)

Share-based payment charge


(1,403)


                      -  


(661)








LOSS BEFORE INCOME TAX

 

(201,058)


(33,841)


(193,932)








Income tax


                        -  


                      -  


                        -  








LOSS AND TOTAL COMPREHENSIVE LOSS FOR THE PERIOD

 

(201,058)


(33,841)


(193,932)








Loss per share

 






- Basic and diluted loss


(0.20)p


(0.03)p


(0.19)p

 



 

Condensed statement of financial position

As at 31 July 2024



31 July

 

31 July

 

31 January

 


2024


2023


2024



(unaudited)

 

(unaudited)

 

(audited)

 


£


£


£

CURRENT ASSETS

 






Trade and other receivables


              66,269


                     -  


                3,847

Cash and cash equivalents


            531,615


         910,589


            792,460



            597,884


          910,589


            796,307








TOTAL ASSETS

 

            597,884


          910,589


            796,307








EQUITY

 






SHAREHOLDERS' EQUITY

 






Called up share capital


        1,000,000


       1,000,000


        1,000,000

Share-based payment reserve


              27,145


            25,081


              25,742

Retained earnings


(493,975)


(132,826)


(292,917)








TOTAL EQUITY

 

           533,170


         892,255


            732,825








CURRENT LIABILITIES

 






Trade and other payables


            64,714


            18,334


             63,482








TOTAL LIABILITIES

 

             64,714


            18,334


              63,482








TOTAL EQUITY AND LIABILITIES

 

           597,884


         910,589


            796,307

 


Condensed statement of changes in equity

For the six months ended 31 July 2024





Share-based

 






Share

 

payment

 

Retained

 




capital

 

reserve

 

earnings

 

 Total

 


£


£


£


£

Unaudited

 








At 1 February 2024


      1,000,000


              25,742


(292,917)


      732,825

Total comprehensive income for the period


                       -  


                        -  


(201,058)


(201,058)

Equity settled share-based payment


                        -  


                 1,403


                      -  


           1,403

At 31 July 2024

 

        1,000,000


              27,145


(493,975)


        533,170










Unaudited

 








At 1 February 2023


      1,000,000


               25,081


(98,985)


        926,096

Total comprehensive income for the period


                       -  


-


(33,841)


(33,841)

At 31 July 2023

 

        1,000,000


              25,081


(132,826)


       892,255










Audited

 








At 1 February 2023


        1,000,000


              25,081


(98,985)


       926,096

Total comprehensive income for the year


                        -  


                       -  


(193,932)


(193,932)

Equity-settled share-based payments


                         -  


                    661


                      -  


                661

At 31 January 2024

 

        1,000,000


               25,742


(292,917)


       732,825

 

Condensed statement of cash flows

For the six months ended 31 July 2024

 



  Six months ended

 

  Six months ended

 

Year ended

 


31 July

 

31 July

 

31 January

 


2024


2023


2024



(unaudited)

 

(unaudited)

 

(audited)

 


£


£


£

Operating activities

 






Loss before income tax


(201,058)


(33,841)


(193,932)

Increase in trade and other receivables


(62,422)


                       -  


(3,847)

Increase/(decrease) in trade and other payables


                 1,232


(15,700)


              29,448

Equity-settled share-based payment charge


                 1,403


                      -  


                   661








Net cash outflow from operating activities

 

(260,845)


(49,541)


(167,670)















Net decrease in cash and cash equivalents

 

(260,845)


(49,541)


(167,670)








Cash and cash equivalents at start of period


           792,460


         960,130


            960,130








Cash and cash equivalents at end of period

 

            531,615


         910,589


            792,460

 



NOTES TO THE UNAUDITED INTERIM ACCOUNTS

FOR THE PERIOD ENDED 31 JULY 2024

1.            General information

Milton Capital Plc is a company incorporated in the United Kingdom, which is listed on the Standard List of London Stock Exchange.  The address of its registered office is The Scalpel, 18th Floor, 52 Lime Street, London EC3M 7AF.

The Company's principal activity is that of a Special Purpose Acquisition Company. Milton was formed with the intention to identify and acquire a suitable business opportunity or opportunities and undertake an acquisition or merger or a series of acquisitions or mergers.

2.            Basis of preparation

The condensed interim financial statements have been prepared in accordance with the Disclosure and Transparency Rules of the United Kingdom's Financial Conduct Authority and with International Accounting Standard ("IAS") 34 "Interim Financial Reporting". It should be read in conjunction with the annual financial statements for the year ended 31 January 2024 for full details of the accounting policies adopted.

The interim financial statements are presented in pounds sterling, rounded to the nearest pound.

The condensed interim financial information for the six months ended 30 July 2024 and 2023 have not been audited or reviewed and do not constitute statutory accounts within the meaning of Section 434 of the Companies Act 2006. The comparative financial information for the year ended 31 January 2024 has been derived from the audited financial statements for that period.  A copy of those statutory financial statements for the year ended 31 January 2024 has been delivered to the Registrar of Companies.  The report of the independent auditors on those financial statements was unqualified and did not contain a statement under Sections 498 (2) or (3) of the Companies Act 2006.

The interim financial statements have been prepared in accordance with International Accounting Standards in conformity with the requirements of the Companies Act 2006 as they apply to the financial statements of the Company for the six months ended 31 July 2024 and as applied in accordance with the provisions of the Companies Act 2006 and under the historical cost convention or fair value where appropriate.  They have also been prepared on a basis consistent with the accounting policies expected to be applied for the year ending 31 January 2025 and which are also consistent with those set out in the statutory accounts of the Company for the year ended 31 January 2024.

3.            Going concern basis of preparation

The Company had approximately £531,615 in cash at the period end. The Directors have prepared the accounts on a going concern basis as they consider that the Company has adequate funding.

4.            Principal risks at 31 July 2024 and key changes since the 2024 annual report

The Directors have reviewed the principal risks facing the Company and concluded for the remaining six months of the financial year that there are no significant changes to those disclosed in the 2024 annual financial statements. A full description of the Company's principal risks can be found on page 10 of the 2024 annual financial statements.



 

5.    Loss per share

The basic loss per share is calculated by dividing the loss attributable to the ordinary shareholders of the Company by the weighted average number of Ordinary shares in issue during the period, excluding Ordinary shares purchased by the Company and held as treasury shares.

 



  Six months ended

 

  Six months ended

 

Year ended

 


31 July

 

31 July

 

31 January

 


2024


2023


2024



(unaudited)

 

(unaudited)

 

(audited)

 







Loss for the financial period


(201,058)


(33,841)


(193,932)








Weighted average number of shares


    100,000,000


 100,000,000


   100,000,000








Basic and diluted loss per share


(0.20)p


(0.03)p


(0.19)p

 

The loss and weighted average number of shares used for calculating the diluted loss per share are identical to those for the basic loss per share. The outstanding share options would have the effect of reducing the loss per share and would therefore not be dilutive under IAS 33 'Earnings per Share'.

5              Dividends

The Directors do not propose to declare a dividend for the period.

6              Copies of interim results

Copies of the interim results can be obtained from the website www.milton-capital.co.uk.  From this site you may access our financial reports and presentations, recent press releases and details about the Company and its operations.

Caution regarding forward looking statements

Certain statements in this announcement, are, or may be deemed to be, forward looking statements.  Forward looking statements are identified by their use of terms and phrases such as ''believe'', ''could'', "should" ''envisage'', ''estimate'', ''intend'', ''may'', ''plan'', ''potentially'', "expect", ''will'' or the negative of those, variations or comparable expressions, including references to assumptions.  These forward-looking statements are not based on historical facts but rather on the Directors' current expectations and assumptions regarding the Company's future growth, results of operations, performance, future capital and other expenditures (including the amount, nature and sources of funding thereof), competitive advantages, business prospects and opportunities.  Such forward looking statements reflect the Directors' current beliefs and assumptions and are based on information currently available to the Directors.

Such statements are based on current expectations and assumptions and are subject to a number of risks and uncertainties that could cause actual events or results to differ materially from any expected future events or results expressed or implied in these forward-looking statements.  Persons receiving and reading this announcement should not place undue reliance on forward-looking statements.  Unless otherwise required by applicable law, regulation or accounting standard, the Company does not undertake to update or revise any forward-looking statements, whether as a result of new information, future developments or otherwise.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR GZGMLFVGGDZM